Anovo Blog

Celebrating Five Consecutive Years as a Top Workplace at Anovo

February 6, 2024

We are thrilled to announce that Anovo has been recognized as a top workplace by The Commercial Appeal for the fifth consecutive year! Being named a top workplace is not just an honor; it’s a validation of our organizational health and the value we place on our employees. The results are based on a quick employee survey, which evaluates organizations based on factors such as employee engagement, company culture, leadership effectiveness, and employee benefits. We prioritize these core elements in everything we do, knowing that they directly contribute to our success and our ability to deliver outstanding patient care.

At Anovo, we believe that our success as a top workplace is directly linked to the passion, dedication, and expertise of our team members. Their efforts drive us forward and enable us to make a meaningful impact in the lives of our patients. As we celebrate this remarkable achievement, we extend our heartfelt gratitude to our incredible team for their hard work and ongoing commitment to providing exceptional care and making a positive difference in the lives of those we serve.


Related Posts

Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria

Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria

Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…

July 29, 2024

Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting

Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting

The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…

June 11, 2024

Pyros and Anovo Partner to Elevate Care for Infantile Spasms

Pyros and Anovo Partner to Elevate Care for Infantile Spasms

Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™…

April 1, 2024

It starts with a conversation. Contact us today.

close